You are here
Effects of Atorvastatin Versus Fenofibrate on Lipoprotein Profiles, Low-Density Lipoprotein Subfraction Distribution, and Hemorheologic Parameters in Type 2 Diabetes Mellitus With Mixed Hyperlipoproteinemia.
Diabetic dyslipoproteinemia characterized by hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, and often elevated low-density lipoprotein (LDL) cholesterol with predominance of small, dense LDL is a strong risk factor for atherosclerosis. It is unclear whether fibrate or...
Tags: Fenofibrate, Atorvastatin, Lipids, Fibrinogen, Plasma viscosity (PV), Erythrocyte aggregation (RBC aggregation), Triglycerides, High-density lipoprotein cholesterol (HDL-C), Low-density lipoprotein cholesterol (LDL-C)
Effect of Supplementation With Dietary Seal Oil on Selected Cardiovascular Risk Factors and Hemostatic Variables in Healthy Male Subjects.
The average daily consumption of seal oil by the Inuit people is approximately 8-9 g, yet there is very little information on the effect of seal oil consumption on cardiovascular disease risk factors. In this study, 19 healthy, normocholesterolemic subjects consumed 20 g of encapsulated seal oil...
This study was designed to characterize blood viscosity changes in 13 patients with mild to moderate diastolic hypertension treated with ramiprilmonotherapy for three months. The ramipril dose was titrated from 2.5 to 20 mg daily to achieve a diastolic blood pressure of less than 90 mm Hg....
Modification of Transoperative Changes in Blood Fluidity by Hydroxychloroquine: A Possible Explanation for the Drug's Antithrombotic Effect.
A study was carried out in 40 patients undergoing minor surgery to investigate the effect of hydroxychloroquine on haemorrheological parameterswhich might explain its reported anti-thrombotic action. Twenty patients received 600 mg to 1400 mg hydroxychloroquine sulphate in the 48-hour period...
The accrued evidence that lipid-lowering therapy limits the progression of atherosclerosis and reduces CAD events is overwhelming. The focus has been on LDL-C reduction with statins, but recent evidence also stresses the importance of raising HDL-C and reducing triglyceride-rich lipoproteins(TRL...
Tags: Fenofibrate, Low-density lipoprotein cholesterol (LDL-C), High-density lipoprotein cholesterol (HDL-C), Plasma viscosity (PV), Apolipoprotein A-I (apo A-I), Fibrinogen
The focus of lipid-lowering therapy with drugs is prevention of complications of atherosclerosis. Landmark clinical trials have demonstrated that lowering low density lipoprotein cholesterol (LDL-C) may not only reduce coronary artery disease (CAD) risk but also may slow the progression and even...
Tags: Atorvastatin, High-density lipoprotein cholesterol (HDL-C), Low-density lipoprotein cholesterol (LDL-C), Plasma viscosity (PV), Fibrinogen, Apolipoprotein A-I (apo A-I)
Effect of Low-Dose Oral Triphasic Contraceptives on Blood Viscosity, Coagulation and Lipid Metabolism.
The purpose of the study was to determine the relationship between hemorheological profile, i.e. blood viscosity, and other risk factors for cardiovascular and thrombotic diseases in women taking oral contraceptives and if blood viscosity may be considered a marker of cardiovascular risk in OC...
Tags: Ethinyl Estradiol and Gestodene, Plasma viscosity (PV), Whole blood viscosity (WBV), Lipids, High-density lipoprotein cholesterol (HDL-C), Apolipoprotein A-I (apo A-I), Fibrinogen, Erythrocyte deformability
Effects of Sorbinicate and Nicotinic Acid on Blood Viscosity, Red Cell Deformation and Platelet Function.
Nicotinic acid (NA) and a retard derivative, sorbinicate, were investigated for their effects on blood rheology and platelet function, after oral administration, in two groups of patients with lower limb atherosclerosis obliterans — the second group having diabetes also. Red cell deformation and...
Tags: Niacin, Plasma viscosity (PV), Fibrinogen, Total cholesterol, Triglycerides, Erythrocyte deformability
BACKGROUND: Coronary heart disease (CHD) is the leading cause of mortality in women, with an incidence that increases after menopause, hencesuggesting a cardioprotective role of oestrogen. Menopause also results in a decline in androgen levels with resulting symptoms of decreased libido and...
Tags: Esterified Estrogens, Methyltestosterone, Plasma viscosity (PV), Fibrinogen, Total cholesterol, Triglycerides, High-density lipoprotein cholesterol (HDL-C)
Effects of Hormone Replacement Therapies on Fibrinogen and Plasma Viscosity in Postmenopausal Women.
In women, cardiovascular morbidity and mortality sharply increase after the onset of menopause. There is substantial evidence that hormone replacement therapy (HRT) may decrease the risk of coronary heart disease (CHD); however, the mechanisms of this preventive effect are unclear. We...
Tags: Estrogens (conjugated), Estrogens (conjugated) and medroxyprogesterone, Plasma viscosity (PV), Fibrinogen